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Abstract 
Epithelial-to-mesenchymal transition (EMT) is a dramatic change in cellular physiology during 
development and metastasis which involves coordination between cell signaling, adhesion, and 
membrane protrusions. These processes all involve dynamic changes in the plasma membrane, yet how 
membrane lipid content regulates membrane function during developmental EMT remains incompletely 
understood. By screening for differential expression of lipid-modifying genes over the course of EMT in 
avian neural crest, we have identified the ceramide-producing enzyme neutral sphingomyelinase 2 
(nSMase2) as a critical regulator of a developmental EMT. nSMase2 expression begins at the onset of 
EMT, and in vivo knockdown experiments demonstrate that nSMase2 is necessary for neural crest 
migration. Further, we find that nSMase2 promotes Wnt and BMP signaling, and is required to activate 
the mesenchymal gene expression program. Mechanistically, we show that nSMase2 is sufficient to 
induce endocytosis, and that inhibition of endocytosis mimics nSMase2 knockdown. Our results support 
a model in which nSMase2 is expressed at the onset of neural crest EMT to produce ceramide and 
induce membrane curvature, thus increasing endocytosis of Wnt and BMP signaling complexes and 
activating pro-migratory gene expression. These results highlight the critical role of plasma membrane 
lipid metabolism in regulating transcriptional changes during developmental EMT programs. 
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Introduction 
Epithelial-to-mesenchymal transition (EMT) is a critical process in both development and metastasis 
during which epithelial cells gain migratory capacity to disperse throughout the body1–3. The 
transcriptional circuits that regulate these events have been at least partially elucidated and appear 
similar in both developmental and metastatic contexts1–3. Moreover, recent studies in cancer cells have 
begun to uncover significant changes in the plasma membrane lipid content during cancer cell EMT4,5. 
These observations raise the intriguing possibility that lipid metabolism functions to promote the EMT 
process by exploiting the structural and bioactive features of plasma membrane lipids. Accordingly, 
sphingolipid metabolism induces EMT in cancer cell lines by reducing ceramide content to suppress 
apoptosis and by producing the signaling lipids sphingosine-1-phosphate (S1P) and lysophosphatidic 
acid (LPA) to enhance proliferation and motility of metastatic cells8–12. Critical roles of bioactive lipids 
during development have also recently emerged. For example, signaling by S1P and LPA also regulate 
developmental cell migration 13–15, and the bioactive lipid ceramide induces neural tube closure defects 
when present at ectopic levels16. However, the functions of plasma membrane lipids during the 
developmental EMTs that precede migration remain less clear.  
To determine how changes in plasma membrane lipid composition regulate developmental EMT in 
vivo, here we examined the avian neural crest, which undergoes a stereotypical EMT during 
development3,17,18. Specified premigratory neural crest cells exhibit epithelial characteristics and enter 
EMT under temporal control by a well-characterized gene regulatory network to adopt a migratory, 
mesenchymal physiology17,19, making it an excellent model to test how membrane lipid changes facilitate 
the transition to a mesenchymal fate. Evidence from the neural crest-derived pediatric cancer, 
neuroblastoma, suggests that lipid metabolism plays a critical role in neural crest biology20,21. In 
neuroblastoma, receptor tyrosine kinase activation is mediated by the organization of Src kinases into 
ordered plasma membrane microdomains20. Formation of ordered microdomains is largely driven by the 
thermodynamic features of membrane lipids22, thus highlighting the importance of understanding plasma 
membrane lipid metabolism during neural crest cell development. 
Here we report that the sphingolipid metabolizing enzyme nSMase2 is necessary for neural crest 
EMT and migration. Mechanistically, our results suggest that nSMase2 activity enables endocytosis of 
cell signaling complexes from the plasma membrane, thereby potentiating Wnt and BMP signaling and 
activating the mesenchymal gene expression program critical for execution of the EMT to a migratory 
phenotype. 
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Results 
Neural crest cells express Smpd3 during epithelial-to-mesenchymal transition and migration 
We predicted that temporally regulated changes in lipid content during EMT would result from 
differential expression of lipid metabolic genes, we explored transcriptome resources comparing chicken 
cranial neural crest cells at premigratory (epithelial) and migratory (mesenchymal) stages23. We parsed 
these data for genes with Gene Ontology terms24 containing “lipid” and found six lipid-related genes 
significantly enriched in epithelial, premigratory neural crest, and nine significantly enriched in 
mesenchymal, migratory neural crest (Fig. 1a,b), consistent with a potential role for lipid modifications 
during neural crest EMT. Of particular interest, the gene SMPD3, which encodes the metabolic enzyme 
neutral sphingomyelinase 2 (nSMase2), showed the most significant enrichment at migratory stages (Fig. 
1a). nSMase2 is a sphingolipid-metabolizing enzyme that functions at the plasma membrane to generate 
ceramide6,7,25. Since sphingolipid metabolism is tightly linked with EMT in cancer4,10,26, we delved further 
into the role of nSMase2 function during developmental neural crest EMT. 
We first examined the spatiotemporal expression pattern of Smpd3, together with the neural crest 
marker Snai2, using Hybridization Chain Reaction (HCR), and found that Smpd3 expression initiated prior 
to EMT in the specified neural crest cells at premigratory stages (HH8+) and remained highly expressed 
following EMT in neural crest cells at migratory stages (HH10-, Fig. 1c-e). We also observed strong 
expression of Smpd3 in the more ventral neural tube and in the notochord (Fig. 1e). Chromogenic in situ 
hybridization confirmed these observations and revealed that Smpd3 expression was not detectable at 
stages earlier than stage HH8 (Supplemental Fig. 1a-e), indicating that Smpd3 expression is initiated just 
prior to neural crest EMT.  
 As a neutral sphingomyelinase enzyme, the SMPD3 gene product, nSMase2, catalyzes the 
hydrolysis of sphingomyelin within the plasma membrane to produce ceramide6,25; thus, we asked if 
ceramide is produced in Smpd3-expressing neural crest cells. Immunolabeling of stage HH11 chicken 
embryos with antibodies against ceramide and the neural crest marker Pax7 revealed strong enrichment 
of ceramide on the apical surface of the neural tube (Supplemental Fig. 1f), correlating with the enriched 
Smpd3 gene expression in this tissue (Fig. 1e). Importantly, ceramide labeling also appeared enriched on 
the surface of migrating neural crest cells (Supplemental Fig. 1f), indicating that ceramide is indeed 
produced in the cranial neural crest. Together these results raise the intriguing possibility that temporally 
regulated sphingolipid metabolism by nSMase2 may play a critical role during neural crest EMT.  
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Fig 1: Identification of Smpd3 enrichment during neural crest epithelial-to-mesenchymal transition. a, Volcano plot 
showing genes significantly enriched within premigratory (negative values) and migratory (positive values) neural crest 
cells. Lipid-related genes with significant differential gene expression are labeled (blue, premigratory enrichment; red, 
migratory enrichment). Data analysis was performed using previously published RNA seq reads23. EMT, epithelial-to-
mesenchymal transition; HH, Hamburger-Hamilton stage. b, Heatmap displaying complete Euclidean clustering shows 
changes in gene expression levels for the lipid-related genes labeled in a between non-neural crest, premigratory, and 
migratory neural crest samples. Each column represents a single biological replicate. c-d, Hybridization chain reaction 
shows Smpd3 and neural crest EMT marker Snai2 expression at premigratory (c) and migratory (d) stages. pNC, 
premigratory neural crest; mNC, migratory neural crest. e, Transverse section through d (dashed line) shows strong 
Smpd3 expression in the neural crest, as well as in the ventral neural tube (NT) and notochord (not). Scale bars represent 
100 µm in c,d and 50 µm in e. See also Supplemental Fig. 1. 
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Ceramide production is required for cranial neural crest migration 
The co-expression of Smpd3 and ceramide during EMT stages led us to hypothesize that the 
SMPD3 gene product, nSMase2, is required for ceramide production in the neural crest. To test this, we 
performed nSMase2 knockdown through bilateral electroporation of a non-binding control antisense 
morpholino (MO) on the left and an nSMase2-targetting MO on the right sides of gastrulating chicken 
embryos. Electroporated embryos were then allowed to develop to migratory stages, at which point 
neural crest cells were visualized (Fig. 2a). Compared to the contralateral control side, nSMase2 
knockdown resulted in significantly decreased ceramide immunolabeling (Fig. 2b), demonstrating that 
nSMase2 is necessary for ceramide production in cranial neural crest cells. 
 Interestingly, Pax7 staining showed control neural crest cells successfully undergoing EMT and 
migrating away from the midline, while loss of nSMase2 on the contralateral side of the same embryos 
resulted in neural crest cells accumulating at the dorsal midline (Fig. 2b). This observation suggested that 
nSMase2-dependent ceramide production is required for neural crest migration. We next examined 
nSMase2 knockdown embryos in whole mount and quantitated the migration area of cranial neural crest 
cells on the control versus nSMase2 knockdown sides. While the control MO did not disrupt neural crest 
migration away from the midline, neural crest cells that received the nSMase2 MO showed a significant 
reduction in migration distance and these cells appeared to accumulate at the midline in the dorsal 
neural tube (Fig. 2c), consistent with our observations in transverse section. Importantly, markers of 
mitosis and apoptosis were unaffected by nSMase2 knockdown within the neural crest (Supplemental 
Fig. 2), and thus aberrant proliferation or survival does not explain the observed reduction in migration. 
To determine if the effect of nSMase2 MO is specific to a loss of nSMase2, we performed a 
second independent method of nSMase2 knockdown using a CRISPR/Cas9-based approach27. 
Compared to a non-targeted gRNA, electroporation of Cas9 with nSMase2-targetting gRNA induced a 
significant reduction in Smpd3 transcripts (Supplemental Fig. 3a), consistent with mutation-induced 
nonsense-mediated decay27,28. We then quantitated the migration area of cranial neural crest cells and 
observed a similar reduction in migration following CRISPR-mediated nSMase2 knockdown compared 
with nSMase2 MO (Supplemental Fig. 3b). Together these results demonstrate that nSMase2 function is 
critical for cranial neural crest migration and suggest that ceramide production by nSMase2 is required 
for EMT in vivo. 
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Fig. 2: nSMase2-mediated ceramide production is required for neural crest EMT. a, Control (blue) and knockdown 
(red) reagents were delivered bilaterally into gastrulating chicken embryos (stage HH4), then embryos were incubated to 
neural crest migration stages for all in vivo electroporation experiments. Perturbations (right side) were then compared to 
the contralateral internal control side (left). b, Embryos were electroporated with a non-binding control morpholino 
(Control MO, left) and nSMase2-targeting morpholino (nSMase2 MO, right), then Pax7 and ceramide were 
immunolabeled in transverse sections through the cranial region at HH9. Parallel coordinate plot shows reduced 
ceramide immunoreactivity within the cranial neural crest region following nSMase2 knockdown (dashed lines in b). c, 
Control or nSMase2 MOs were electroporated together with H2B-RFP to display transfection efficiency. Pax7 
immunolabeling shows failure of neural crest cells to migrate away from the midline following nSMase2 knockdown. 
Parallel coordinate plot displays normalized Pax7+ neural crest migration area, demonstrating significantly reduced 
neural crest migration following nSMase2 MO electroporation. Scale bars represent 50 µm (b) and 100 µm (c). **p <0.01, 
****p<0.0001, two-tailed paired t-test. Each point in b represents the mean of three sections from an individual embryo 
(n=10 embryos), and each point in c represents one embryo with lines connecting measurements from the same embryo 
(n=27 embryos). 
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nSMase2 is required to activate pro-migratory gene expression changes 
 The observed loss of cranial neural crest migration upon nSMase2 knockdown may result from a 
defect in activating migratory gene regulatory circuits or from disruption of the downstream cellular  
mechanisms underlying neural crest migration. To differentiate between these possibilities, we performed 
HCR to examine the expression of multiple markers that reflect neural crest specification (Msx1) and 
EMT progression (Sox9 and Snai2)17,19. The activation of Snai2 expression during EMT directly represses 
expression of the premigratory cadherin CAD6B in neural crest cells29, and thus we also examined 
expression of Cad6b as a premigratory marker in nSMase2 morphants. nSMase2-deficient neural crest 
displayed significant downregulation of Msx1, Sox9, and Snai2 expression, and elevated expression of 
Cad6b transcripts (Fig. 3a, Supplemental Fig. 4). We next performed immunolabeling for Snail2 and 
Cad6B and, consistent with the HCR results, nSMase2 knockdown reduced Snail2 and elevated Cad6B 
protein levels in the cranial neural crest (Fig. 3b). Together these results indicate that nSMase2 is 
necessary to activate pro-EMT gene expression, most dramatically upregulating Sox9 and Snai2 
expression. These observations suggest that nSMase2 activity promotes the transition from premigratory 
to migratory neural crest gene signatures during EMT, and the loss of migration observed in nSMase2-
deficient neural crest reflects a failure to activate the mesenchymal gene expression program. 
 
Wnt and BMP signaling pathways require nSMase2 function 
 Activation of the EMT gene regulatory network in neural crest involves the canonical Wnt and 
BMP pathways17,19,30, and we hypothesized that sphingolipid metabolism at the plasma membrane may 
alter the activity of these pathways7,31. To test this, we turned to GFP reporter constructs which measure 
canonical Wnt (TCF/Lef::H2B-d2eGFP) and BMP (BRE::eGFP) pathway output in cranial neural crest 
cells32–35. We electroporated these reporters together with control or nSMase2 MOs, then compared GFP 
intensity within the cranial neural crest. At the onset of EMT at stage HH9-, we observed a significant 
reduction in Wnt/β-catenin signaling upon nSMase2 knockdown (Fig. 3c). That SNAI2 is a direct target of 
Wnt signaling36 explains the observed loss of Snai2 expression (Fig. 3a). Similarly, we observed a 
significant reduction in BMP signaling activity (Fig. 3c), consistent with the reduced expression of Msx1 
(Fig. 3a), a downstream target of BMP signaling37. Together these results demonstrate that nSMase2 
function is required for signaling cascades, including the Wnt and BMP pathways, originating from the 
plasma membrane. 
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Fig. 3: nSMase2 is required for the transcriptional activation of the EMT program and for Wnt and BMP signaling. 
a, Relative mRNA expression for neural crest markers in nSMase2 knockdown embryos at stage HH9- (representative 
images displayed in Supplemental Fig. 4, Msx1 n=7 embryos, Sox9 n=7 embryos, Snai2 n=9 embryos, Cad6b n=7 
embryos). b, Immunolabeling for Snai2 and Cad6B proteins in nSMase2 knockdown sections at HH9. Boxplot shows 
relative Snai2 and Cad6B protein levels as measured by fluorescence intensity (Snail2 n=8 embryos, Cad6B n=8 
embryos). c, nSMase2 knockdown reagents were electroporated together with the Wnt-responsive TCF/Lef::H2B-
d2EGFP (left panel) or the BMP-responsive BRE::eGFP (center panel) constructs and imaged in transverse sections at 
HH9- and HH10-, respectively. Relative eGFP fluorescence intensity within the Pax7+ neural crest domain shows a 
significant reduction in Wnt and BMP output in nSMase2-depleted neural crest cells (TCF/Lef n=9 embryos, BRE n=8 
embryos). Scale bars represent 50 µm. *p<0.05, **p <0.01, two-tailed paired t-test. Each point in a represents one 
embryo, and in b,c represents the mean of three sections from individual embryos. 
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nSMase2 expression is sufficient to induce endocytosis  
 We next sought to mechanistically test the role of sphingolipid metabolism at the plasma 
membrane in the activation of developmental signaling. Wnt and BMP signaling components collect 
within sphingolipid- and cholesterol-rich membrane microdomains, such as caveolae22,38,39. Ceramide 
production within such microdomains is sufficient to induce membrane curvature and internalization40–43, 
thus resulting in the internalization of microdomain-localized proteins. Importantly, endocytosis of Wnt 
and BMP/TGF-β complexes into signalosomes facilitates the most potent signaling output39,44–47. This 
raised the possibility that nSMase2 function promotes endocytosis of membrane microdomains, thus 
explaining the reduction in Wnt and BMP signaling following nSMase2 knockdown.  
We tested this hypothesis by assaying endocytosis in the epithelial U2OS cell line that bears 
morphological similarity to premigratory neural crest. To this end, we employed fluorescently labeled 
Transferrin (Tf-633) as a readout for receptor-mediated endocytosis48. Cells were transfected with control 
or perturbation constructs, then exposed to Tf-633 for 30 minutes in the culture media before fixation, 
imaging, and quantitation of Tf-633-positive endocytic puncta. Compared with an RFP-only transfection 
control, transfection of a dominant-negative Dynamin 1 mutant (Dyn1(K44A))49,50 resulted in reduced Tf-
633 internalization (Fig. 4a), as predicted. Next, we found that nSMase2 overexpression was sufficient to 
increase Tf-633 internalization (Fig. 4a), consistent with our hypothesis that nSMase2 expression in the 
premigratory neural crest activates endocytosis. Finally, we generated a mutant of nSMase2 
(nSMase2(N130A)) lacking catalytic function 51, and found that without its catalytic activity, 
nSMase2(N130A) overexpression had no effect on endocytosis (Fig. 4a). These results support our 
model in which nSMase2 expression in epithelial cells, similar to premigratory neural crest cells, activates 
endocytosis through the conversion of sphingomyelin into ceramide and results in active cell signaling.  
 
Inhibition of endocytosis phenocopies loss of nSMase2 during neural crest EMT 
 To test this model in vivo, we asked if endocytosis is required for neural crest EMT. If so, inhibition 
of endocytosis within the neural crest during EMT should reproduce the phenotypes observed following 
nSMase2 knockdown. To this end, we inhibited endocytosis specifically within cranial neural crest cells 
by expressing the dominant negative Dyn1(K44A) mutant under control of the neural crest-specific 
FoxD3 NC1.1m3 enhancer52 (m3::Dyn1(K44A)). Following electroporation of m3::Dyn1(K44A), we 
observed reduced Wnt/β-catenin signaling at EMT stages within the cranial neural crest cells (Fig. 4b). 
We then examined neural crest migration following m3::Dyn1(K44A) electroporation and found that 
endocytosis was required during EMT for cranial neural crest migration (Fig. 4c). These data together 
indicate that endocytosis is required during neural crest EMT for Wnt/β-catenin signaling and for 
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migration, thus phenocopying nSMase2 knockdown and suggesting that endocytosis acts downstream 
of nSMase2 function during neural crest EMT. 
 
Fig. 4: nSMase2 is sufficient to induce endocytosis, and endocytosis is necessary for neural crest EMT. a,  
Epithelial cells (U2OS) were transfected with GPI-eGFP to label the plasma membrane and the indicated overexpression 
constructs. After 24 hours, transfected cells were incubated with Transferrin-Alexa-633-conjugate (Tf-633) in the culture 
media for 30 minutes to allow for receptor-mediated endocytosis. Cells were then fixed and visualized by confocal 
microscopy. Scale bars represent 10 µm. Cumulative distribution frequency (CDF) plot displaying the number of 
fluorescent Tf-633 puncta within individual transfected cells. CDF curves shifted to the left are consistent with reduced 
endocytosis, while curves shifted to the right are indicative of elevated endocytic activity (n=50 RFP, 35 Dyn1(K44A), 29 
nSMase2, and 36 nSMase2(N130A) cells). ns not significant, *p<0.05, ****p<0.0001; Kruskal-Wallis test (p=2.69e-9) with 
Dunn’s posthoc analysis. b, The Wnt-responsive TCF/Lef::H2B-d2eGFP reporter was coelectroporated with the 
dominant negative Dyn1(K44A) under control of the neural crest-specific FoxD3 NC1.1m3 enhancer (m3::Dyn1(K44A)). 
Embryos were collected and examined in transverse section at HH9+. Normalized eGFP fluorescence quantitation 
shows reduced Wnt signaling following Dyn1(K44A) expression compared to a non-expressing pBluescript (pBS) control 
(n=10 sections from 3 embryos). **p<0.01; two-tailed paired t-test. Scale bar represents 50 µm. c, Embryos were 
electroporated with m3::Dyn1(K44A) and examined in whole mount at HH9+ for neural crest migration by Pax7 
immunolabeling. Neural crest migration was quantitated from endocytosis-inhibited embryos, revealing a reduction in 
migration area. Comparing relative migration area between m3::Dyn1(K44A) embryos with nSMase2 knockdown 
embryos shows that endocytosis inhibition phenocopies nSMase2 knockdown (n=17 m3:Dyn1(K44A) and 27 nSMase2 
MO embryos). ns not significant; two-tailed unpaired t-test. Each point represents one embryo. Scale bar represents 100 
µm. nSMase2 MO data is reproduced here from Fig. 2c.  
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Discussion 
 Here we show that premigratory neural crest cells initiate expression of nSMase2 to convert 
plasma membrane sphingomyelin into ceramide in preparation for EMT. Ceramide production has strong 
effects on lateral membrane organization by forming microdomains22,53–55 that drive receptor clustering 
and plasma membrane curvature40,55. We find that the production of ceramide is required for Wnt and 
BMP signaling during neural crest EMT, likely by promoting endocytosis of activated signaling 
complexes38,39,44–47,56. Accordingly, we find that nSMase2 is sufficient to induce endocytosis, and 
inhibition of endocytosis mimics the effects of nSMase2 knockdown in cranial neural crest EMT. Thus, 
our results suggest that temporally regulated ceramide production by nSMase2 mechanistically activates 
endocytosis to facilitate neural crest EMT and migration (Fig. 5). The results reveal that changes in lipid 
metabolism are a critical driver of developmental cell signaling that is required for the transition to a 
migratory phenotype. 
In cancer cell lines, ceramide production shows pro-apoptotic effects, thereby inhibiting EMT; 
instead, EMT and motility are enabled by the downregulation of ceramide or the upregulation of 
sphingomyelin production8–10. These observations contrast with our findings during developmental EMT, 
where ceramide production instead activates EMT gene expression (Fig. 3) and motility (Fig. 2c) without 
affecting proliferation or apoptosis (Supplemental Fig. 2). Our model suggests that the removal of 
sphingomyelin is necessary for mesenchymalization during development. Consistent with this, in 
collecting duct cells sphingomyelin synthesis is required to maintain epithelial properties57. Together, 
these observations suggest that sphingomyelin and ceramide have opposite effects in developmental 
versus metastatic EMT progression. It will be of great interest to determine the context-specific 
mechanisms that regulate this differential response. 
The observation that nSMase2 function increases Transferrin endocytosis (Fig. 4a) is very 
intriguing given the lateral organization of Transferrin receptors on the plasma membrane. Transferrin 
binds preferentially within disordered membrane microdomains58, whereas sphingomyelin and ceramide 
are enriched within more ordered microdomains53. How sphingomyelin metabolism in ordered 
microdomains causes endocytosis of disordered microdomain-localized proteins remains an 
unanswered question. There is evidence that SMase function enables endocytosis of ordered caveolar 
membrane microdomains. Sphingomyelin within caveolae stabilizes plasma membrane invaginations, 
and treatment with SMase decreases sphingomyelin content and reduces caveolae stability43. Since 
activated Wnt and BMP receptors localize to caveolae22,38,39, this supports the notion that nSMase2-
dependent conversion of sphingomyelin into ceramide in neural crest cells enables internalization of Wnt 
and BMP receptor complexes within caveolae. Together, these findings highlight how dynamic changes 
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in lipid metabolism alter plasma membrane function to enable endocytosis and have broad reaching 
effects on critical developmental processes such as EMT and cell migration. 
 
 
Fig. 5: nSMase2 regulates endocytosis to enable neural crest EMT. Premigratory neural crest cells have  
sphingomyelin-rich membrane microdomains. At the onset of EMT, nSMase2 expression converts sphingomyelin into 
ceramide to promote membrane curvature. This facilitates the endocytosis of activated signaling complexes (Wnt and 
BMP). Internalization of these complexes enables activation of pro-EMT transcriptional targets (including Snai2 and 
Sox9) which promote neural crest EMT and migration. 
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Materials and Methods 
RNA Seq Analysis 
 Bulk RNA Seq reads from FACS-isolated FoxD3-positive premigratory (HH8+ to HH9-) and 
migratory (HH9+ to HH10) chicken cranial neural crest cells, and FoxD3-negative non-neural crest cells, 
were downloaded from GEO (BioProject PRJNA497574)23. Reads were trimmed using Cutadapt59 and 
aligned to the chicken genome (GRCg6a) using BowTie260. Transcripts were then counted using 
featureCounts61 and differential expression analysis between premigratory and migratory gene 
expression was carried out using DESeq262. Volcano plot analysis (Fig. 1a) highlights genes with lipid-
related GO terms24 with an adjusted p-value < 0.05, base mean value > 45, and log2-fold change value > 
0.7. Complete Euclidean distance clustering was performed using pheatmap63 (Fig. 1b), and displays 
each premigratory, migratory, and non-neural crest cell biological replicate. 
 
Embryos and perturbations 
Fertilized chicken eggs were obtained from commercial sources (Sunstate Ranch, Sylmar, CA and 
AA Lab Eggs, Westminster, CA). Ex ovo electroporations were performed using five pulses of 5.6 V for 50 
ms at 100 ms intervals and cultured in albumin with 1% penicillin/streptomycin, then incubated to the 
desired HH stage64,65. For transverse sections, fixed embryos were incubated in 5% sucrose for 30 
minutes at room temperature, 15% sucrose overnight at 4°C, 7.5% gelatin at 39°C overnight, flash-
frozen in liquid nitrogen, and cryosectioned at a thickness of 18 µm. All reagents electroporated either 
expressed a fluorescently-tagged protein or were co-electroporated with nuclear GFP- or RFP-
expressing constructs66,67; fluorescent protein expression was used to screen for electroporation 
efficiency and only embryos with high efficiency were included in analysis. Morpholinos were 
electroporated at 0.8 mM and synthesized with the following sequences (Gene Tools): control MO (5’-
CCTCTTACCTCAGTTACAATTTATA-3’), translation-blocking nSMase2 MO (5’- 
GGTGTCACTGTGTCAAGCATCCATA-3’). pTK-FoxD3-NC1.1m3::Dyn1(K44A) over-expressing constructs 
were electroporated at 1.5 µg/µl. CRISPR-mediated knockdown was performed using a plasmid-based 
strategy, and a nonbinding control gRNA (5’-GCACTGCTACGATCTACACC-3’), and a nSMase2-
targeting gRNA designed within the first exon of the SMPD3 gene locus (5’-
GCAATCTGCGCAGCCCGAGA-3’), each at 1.5 µg/µl concentrations, were co-expressed with a Cas9-
expressing plasmid (1.5 µg/µl) as previously described27. 
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Hybridization chain reaction and in situ hybridization 
Reagents for third-generation hybridization chain reaction were purchased from Molecular 
Technologies, and hybridization experiments were performed following manufacturer’s instructions68. 
Probe sets were designed against Smpd3 (B1 initiator), Snai2 (B4), Cad6b (B5), Sox9 (B5), Msx1 (B4), 
and Tfap2b (B7), and detected using appropriate amplifier hairpins labeled with Alexa488, Alexa546, and 
Alexa647. For chromogenic in situ hybridization, a 970 bp fragment of the chicken Smpd3 transcript, 
corresponding to 76 bp of the 5’ untranslated region and first 894 bp of open reading frame was 
amplified by PCR from stage HH9 cDNA using primers ‘nSMase2 FWD -76’ and ‘nSMase2 REV 894 T7’ 
(Supplemental Table 1). RNA probes were synthesized and labeled with DIG (Roche) using the T7 RNA 
polymerase (Promega) and purified with Illustra Probe-Quant G-50 Micro Columns (GE Healthcare). 
Hybridization and probe detection were carried out as previously described35. 
 
Immunohistochemistry 
 For immunofluorescence analysis, embryos were fixed for 20 minutes at room temperature in 4% 
PFA in phosphate buffer, and all subsequent washes and incubations were performed in TBST + Ca2+ (50 
mM Tris-HCl, 150 mM NaCl, 1 mM CaCl2, 0.5% Triton X-100). Blocking was performed in 10% donkey 
serum for 2 hours at room temperature, and primary and secondary antibody incubations were carried 
out in 10% donkey serum for 2 nights at 4°C. Primary antibodies employed in this study include mouse 
IgG1 anti-Pax7 (1:10; DSHB #PAX7), mouse IgM anti-HNK-1 (1:5; DSHB #3H5), mouse IgG1 anti-Cad6B 
(1:5; DSHB #CCD6B-1), mouse IgM anti-ceramide (1:200; Sigma #MID15B4), rabbit anti-phosphohistone 
H3 (1:500; EMD Millipore #06-570), rabbit anti-cleaved caspase 3 (1:300; R&D Systems #AF835), rabbit 
anti-Snai2 (1:500; Cell Signaling Technologies #9585), goat anti-GFP (1:500; Rockland #600-101-215M), 
and rabbit anti-RFP (1:500; MBL #PM005). Alexa Fluor 350-, 488-, 568-, 633-, or 647-conjugated donkey 
secondary antibodies (1:500; Molecular Probes) were used to detect primary antibodies.  
 
Construct design and cloning 
 Cloning was performed by a combination of PCR reactions with high-fidelity DNA polymerase 
AccuPrime (ThermoFisher), and restriction digestion and ligation (enzymes from NEB). A 5’ Kozak 
consensus sequence was introduced to promote efficient translation of each overexpression construct, 
and all constructs were sequence verified before use. All primer sequences are presented in 
Supplemental Table 1. CMV::Dyn1(K44A)-mRFP (Addgene plasmid #55795) 49, pCAG::GPI-eGFP 
(Addgene plasmid #32601)69, TCF/Lef::GFP (Addgene plasmid #32610)32, M38-TOP::d2EGFP (Addgene 
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plasmid #17114) and BRE::GFP34 constructs were generous gifts from Catherine Berlot, Anna-Katerina 
Hadjantonakis, Randall Moon, and Elisa Martí. 
The nSMase2 open reading frame was amplified from cDNA using ‘nSMase2 ATG XhoI’ and 
‘nSMase2 stop ClaI’ primers and ligated into pCI::H2B-RFP66 between the XhoI and ClaI sites to produce 
pCI::nSMase2. The nSMase2(N130A) mutation was inserted by amplifying the 5’ and 3’ fragments of 
nSMase2 from cDNA using ‘nSMase2 FWD -76’ and ‘nSMase2 N130A REV’, and ‘nSMase2 N130A 
FWD’ and ‘nSMase2 2462 REV’, respectively. These PCR fragments were then fused by amplification 
with ‘nSMase2 ATG XhoI’ and ‘nSMase2 stop ClaI’ and ligated into pCI::H2B-RFP between the XhoI and 
ClaI sites, producing pCI::nSMase2(N130A). pCAG::nSMase2-RFP was produced by amplifying the 
nSMase2 open reading frame without the stop codon from pCI::nSMase2 using ‘nSMase2 ATG SphI’ 
and ‘nSMase2 nostop ClaI’ primers, and amplifying RFP from pCI::nSMase2 using ‘RFP ATG ClaI’ and 
‘RFP stop NotI’ primers. These fragments were digested and ligated together between the SphI and NotI 
sites of pCI::H2B-RFP. pCAG::2a-RFP was produced to introduce a self-cleaving 2a peptide sequence 
immediately upstream of RFP. The RFP sequence was amplified from pCI::H2B-RFP, and the 2a 
sequence was synthetically added by sequential amplification with ‘2a-RFP FWD 1’, then ‘2a-RFP FWD 
2’, then ‘2a-RFP FWD 3 ClaI’, each with ‘RFP stop NotI’. The resulting 2a-RFP sequence was then 
ligated into pCI::H2B-RFP between the ClaI and NotI cut sites. pTK-FoxD3-NC1.1m3::Dyn1(K44A)-RFP 
was produced by digesting pTK-FoxD3-NC1.1m3::GFP52 with NheI and XbaI. CMV::Dyn1(K44A)-RFP 
was grown in One Shot INV110 dam- E. coli (ThermoFisher) to prevent XbaI methylation and was 
similarly digested with NheI and XbaI. The resulting products were ligated together and sequenced to 
confirm orientation. Finally, GFP was replaced in TCF/Lef::H2B-GFP32 with d2EGFP from M38- 
TOP::d2EGFP by digestion and ligation between the AgeI and NotI cut sites. 
 
Tissue culture, transfection, and endocytosis assays 
 Human osteosarcoma U2OS cells (ATCC #HTB-96) were cultured at 37°C in 50% CO2 in McCoy’s 
5A Modified Media (ThermoFisher) supplemented with 10% fetal bovine serum (Gibco) and 1% 
penicillin/streptomycin (Corning). Cells were seeded for transfection in 8-well glass bottom chamber 
slides (ibidi # 80827) and transfected using Lipofectamine 3000 (Invitrogen) at 80% confluency then 
incubated for 24 hours. Culture media was replaced with 25 µg/mL Transferrin-Alexa-633-conjugate 
(ThermoFisher #T23362) in serum-free DMEM (ThermoFisher) and incubated at 37°C for 30 minutes. 
Cells were then washed 2x with DPBS (ThermoFisher) and fixed with 4% PFA in PBS for 10 minutes at 
room temperature before imaging.  
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Microscopy and image analysis 
 Whole mount and transverse section imaging was performed using a Zeiss Imager.M2 with an 
ApoTome.2 module or with a Zeiss LSM 880 upright confocal microscope. All transverse section images, 
as well as whole mount embryo images (Fig. 1c,d, Supplemental Fig. 3a, and Supplemental Fig. 4) 
display maximum intensity projections of Z-stacks. Whole mount embryo images (Fig. 2c, Fig. 4c, and 
Supplemental Fig. 3b) display wide-field views. Cell culture experiments were imaged using a Zeiss LSM 
800 inverted confocal microscope and displayed as single focal plane images. Images were analyzed 
and prepared for display using Fiji70. Regions of interest were manually drawn to measure fluorescence 
intensity and neural crest migration area, and to define boundaries for particle counting. For Tf-633 
particle counting, images were subjected to median filtering, then thresholding using the Triangle method 
in the Auto Threshold tool. Analyze Particles was then used to count puncta with areas between 0.25 
and 15.0 µm2. For PH3-positive cell counting, median filtered images were thresholded using the 
Bernsen method with the Auto Local Threshold tool and the Analyze Particles feature then was used to 
quantitate particles larger than 20.0 µm2. For cleaved-Casp3 quantitation, median filtered images were 
subjected to uniform manual thresholding and Analyze Particles was used to count puncta larger than 3 
µm2. 
 
Statistical analysis 
Parallel coordinate plots (Fig. 2b,c, Fig. 4b, and Supplemental Fig. 3b) show the control and 
experimental measurements, normalized to the mean of the control group, with solid lines connecting 
values from the same embryo. Box plots (Fig. 3, Fig. 4c, and Supplemental Fig. 3a) display the ratio of 
experimental divided by corresponding control measurements, with the following box plot elements: 
center line, median; box limits upper and lower quartiles; whiskers, minimum and maximum values; 
points, individual embryo measurements. Statistical analyses were performed using GraphPad Prism 8 
software. All t-tests were two-tailed and paired, with the exception of one two-tailed, unpaired t-test (Fig. 
4c). All embryo analyses show pooled results from at least three independent experiments, and all t-tests 
passed power analysis in G*Power 3.171 at a power cutoff of 0.80. Cumulative distribution frequency 
analysis for Tf-633 endocytosis shows pooled results from two independent experiments and was 
performed in Python using iqplot72. Kruskal-Wallis test with Dunn’s posthoc analysis was used for 
statistical analysis of cumulative distribution frequencies. 
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Supplemental Fig. 1: Smpd3 gene expression is detected in premigratory and migratory cranial neural crest cells. 
In situ hybridization shows that Smpd3 expression is absent at early stages (a), initiates in specified, premigratory neural 
crest cells (b), and is maintained during migration (c,d). e,  
Transverse section of embryos at stage HH10 (c, dashed line) shows Smpd3 expression in migrating cranial neural crest 
cells, immunolabeled by the surface antigen HNK-1. HH, Hamburger Hamilton stage; pNC, premigratory neural crest; 
mNC, migratory neural crest. See also Fig. 1. f, Immunolabeling reveals enrichment of the lipid ceramide in Pax7-labeled 
migrating neural crest cells at stage HH11, as well as along the apical surface of the neural tube. 
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Supplemental Fig. 2: nSMase2 knockdown does not affect neural crest proliferation or survival. Gastrulating chick 
embryos were electroporated with a non-binding control morpholino (Control MO, left) and nSMase2-targeting 
morpholino (nSMase2 MO, right), and where subsequently immunostained for the neural crest marker Pax7 and the 
mitotic marker phospho-histone H3 (PH3, a), or for the apoptosis indicator, activated caspase 3 (cleaved Casp3, c) in 
section at the HH9+. Quantitation of PH3+ (n=27 sections from 9 embryos, b) and Casp3+ (n=15 sections from 5 
embryos, d) cells show no significant change between nSMase2 knockdown and the contralateral control. Displayed is 
the mean with error bars reflecting sem. Scale bars represent 50 µm. ns, non-significant; two-tailed paired t-test. 
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Supplemental Fig. 3: CRISPR-mediated nSMase2 knockout phenocopies nSMase2 MO. Embryos were 
electroporated with a Cas9-eGFP-expressing construct, together with U6.3-driven control- or nSMase2-targeting 
gRNAs. a, At HH9, embryos were fixed and processed for HCR to detect expression of Smpd3 transcripts and the 
neural crest marker Tfap2b. Box plot shows relative fluorescent intensity shows reduced Smpd3 expression following 
nSMase2 gRNA electroporation compared with control gRNA (n=7 embryos). b, Pax7 staining in nSMase2 CRISPR-
electroporated embryos reveals a significant reduction in cranial neural crest migration area (n=8 embryos). Scale bars 
represent 100 µm. **p <0.01, two-tailed paired t-test. See also Fig. 2. 
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Supplemental Fig. 4: nSMase2 knockdown disrupts activation of the EMT transcriptional program. Representative 
images of nSMase2 knockdown embryos coelectroporated with nls-eGFP to label transfected cells, followed by HCR 
analysis for expression of neural crest markers Msx1, Sox9, Sna2, and Cad6b at stage HH9-. Scale bars represent 100 
µm. See quantitation in Fig. 3a. 
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Supplemental Table 1. Primer sequences employed in this study.
Construct Generated PCR Product Primer Name Sequence (5'-->3')
nSMase2 FWD -76 CCTCAGTGTTGCTATGGATGC
nSMase2 REV 894 T7 TAATACGACTCACTATAGGGAACTGCCAGAATCTCCATCC
nSMase2 ATG XhoI ATATCTCGAGGCCACCATGGTTTTATATACTTCCCCAT
nSMase2 stop ClaI ATATATCGATTTAAGGATCATCTTCTCCTGTAG
nSMase2 FWD -76 CCTCAGTGTTGCTATGGATGC
nSMase2 N130A REV GCAGCAGGCAAACGGCGGCACTGCCAAAGC
nSMase2 N130A FWD GCTTTGGCAGTGCCGCCGTTTGCCTGCTGC
nSMase2 2462 REV CATGCTACTGATGCAAGCACG
nSMase2 ATG XhoI ATATCTCGAGGCCACCATGGTTTTATATACTTCCCCAT
nSMase2 stop ClaI ATATATCGATTTAAGGATCATCTTCTCCTGTAG
nSMase2 ATG SphI TAGAGCATGCTATTATGCCACCATGGTTTTATATAC
nSMase2 nostop ClaI CTCCATCGATTCCTCCTCCAGGATCATCTTCTCCTGTAGAC
RFP ATG ClaI AGGAATCGATGGAGGAGGAATGGCCTCCTCCGAGGACGTC
RFP stop NotI ATATGCGGCCGCTTAGGCGCCGGTGGAGTGGCG
2a-RFP FWD 1 CGGGGACGTGGAGGAAAATCCCGGCCCTGAAATGGCCTCCTCCGAGGACG
2a-RFP FWD 2 CTCCGGCGAGGGCAGGGGAAGTCTTCTAACATGCGGGGACGTGGAGGAAAATCC
2a-RFP FWD 3 ClaI AGCTCATCGATGCCGCCACCATGGGCTCCGGCGAGGGCAGGGG
RFP stop NotI ATATGCGGCCGCTTAGGCGCCGGTGGAGTGGCG
pCAG::2a-RFP 2a-RFP
Smpd3  ISH probe Smpd3  ISH probe template
pCI::nSMase2 nSMase2 open reading frame
nSMase2 N130A 5' fragment
nSMase2 N130A 3' fragment
nSMase2 N130A fusion product
pCI::nSMase2(N130A)
pCAG::nSMase2-RFP
nSMase2 open reading frame 
(no stop codon)
RFP
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